These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 22586027)
1. ACP Journal Club. Review: biologic agents increase short-term risk for some adverse events in conditions other than HIV or AIDS. Schattner A Ann Intern Med; 2012 May; 156(10):JC5-9. PubMed ID: 22586027 [No Abstract] [Full Text] [Related]
2. ACP Journal Club. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD. Hsu CY Ann Intern Med; 2010 Nov; 153(10):JC5-3. PubMed ID: 21079210 [No Abstract] [Full Text] [Related]
4. ACP Journal Club: review: varenicline for tobacco cessation does not increase CV serious adverse events. Krebs P; Sherman SE Ann Intern Med; 2012 Aug; 157(4):JC2-2. PubMed ID: 22910956 [No Abstract] [Full Text] [Related]
5. ACP Journal Club: review: dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes. Chatterjee S; Chatterjee S Ann Intern Med; 2013 Apr; 158(8):JC8. PubMed ID: 23588773 [No Abstract] [Full Text] [Related]
6. ACP Journal Club. Review: Varenicline increases risk for serious adverse cardiovascular events in tobacco users. Brophy JM Ann Intern Med; 2011 Oct; 155(8):JC4-5. PubMed ID: 22007064 [No Abstract] [Full Text] [Related]
7. ACP Journal Club. Review: daily aspirin reduces short-term risk for cancer and cancer mortality. Diehl AK Ann Intern Med; 2012 Jul; 157(2):JC2-2, JC2-3. PubMed ID: 22801694 [No Abstract] [Full Text] [Related]
8. ACP Journal Club. Anti-TNFalpha therapy did not increase short- or medium-term risk for cancer in patients with rheumatoid arthritis. Smith M Ann Intern Med; 2010 May; 152(10):JC5-13. PubMed ID: 20479018 [No Abstract] [Full Text] [Related]
9. ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes. Melnikow J Ann Intern Med; 2010 Mar; 152(6):JC3-4. PubMed ID: 20231558 [No Abstract] [Full Text] [Related]
10. ACP Journal Club. Review: lithium is associated with adverse events in patients with mood disorders. Preda A Ann Intern Med; 2012 Jul; 157(2):JC2-10. PubMed ID: 22801701 [No Abstract] [Full Text] [Related]
11. ACP Journal Club. Review: Dopamine agonists are effective for the restless legs syndrome but may be discontinued due to adverse events. Andolsek KM Ann Intern Med; 2011 Jul; 155(2):JC1-9. PubMed ID: 21768575 [No Abstract] [Full Text] [Related]
12. ACP Journal Club. Testosterone increased risk for adverse events in older men with mobility limitations. Lichtenstein MJ Ann Intern Med; 2010 Dec; 153(12):JC6-7. PubMed ID: 21173408 [No Abstract] [Full Text] [Related]
13. ACP Journal Club. Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients. Basu A Ann Intern Med; 2010 Feb; 152(4):JC-213. PubMed ID: 20157125 [No Abstract] [Full Text] [Related]
14. ACP Journal Club. Review: Preoperative brain natriuretic peptide level is an independent predictor of adverse cardiovascular events after noncardiac surgery. Kaw R; Cai O Ann Intern Med; 2010 Mar; 152(6):JC3-12. PubMed ID: 20231554 [No Abstract] [Full Text] [Related]
15. ACP Journal Club. Review: Corticosteroids improve short-term outcomes but worsen longer-term outcomes in some types of tendinopathy. Margo KL Ann Intern Med; 2011 Feb; 154(4):JC2-5. PubMed ID: 21320932 [No Abstract] [Full Text] [Related]
16. ACP Journal Club. Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease. Stanbrook MB Ann Intern Med; 2009 Jan; 150(2):JC1-6, JC1-7. PubMed ID: 19172711 [No Abstract] [Full Text] [Related]